Go Pro
→ Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” (From Paradigm Press) (Ad)tc pixel Free CNK Stock Alerts

Cinemark (CNK) Financials

Cinemark logo
$35.06 +0.07 (+0.20%)
As of 03:58 PM Eastern
Compare
Annual Income Statements for Cinemark

Annual Income Statements for Cinemark

This table shows Cinemark's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 217 255 264 214 191 -1,310 -423 -271 188 310 138
Consolidated Net Income / (Loss)		 219 257 266 215 194 -1,843 -1,225 -765 400 637 290
Net Income / (Loss) Continuing Operations		 219 257 266 215 194 -1,312 -751 -519 44 363 27
Total Pre-Tax Income 		348 361 345 311 274 -2,766 -1,290 -772 680 774 517
Total Operating Income		 423 423 392 388 338 -1,568 0.00 0.00 0.00 0.00 0.00
Total Gross Profit		 2,087 2,117 2,143 2,334 2,320 -290 1,045 1,709 2,261 2,246 2,293
Total Revenue		 2,853 2,919 2,992 3,222 3,283 0.00 1,511 2,455 3,067 3,050 3,115
Operating Revenue		 2,702 2,919 2,992 3,222 3,283 - 1,511 2,455 3,067 3,050 3,115
Total Cost of Revenue		 765 802 849 888 963 290 466 745 806 804 822
Operating Cost of Revenue		 765 802 849 888 963 290 466 745 806 804 822
Total Operating Expenses		 1,664 1,694 1,750 1,945 1,982 1,491 1,701 2,055 1,973 1,945 2,050
Selling, General & Admin Expense		 513 499 508 613 648 712 885 1,167 1,328 1,351 1,438
Marketing Expense		 946 963 967 1,000 1,004 - 0.00 0.00 0.00 0.00 0.00
Depreciation Expense		 189 209 238 261 261 779 796 715 629 593 606
Impairment Charge		 8.80 2.84 15 32 57 - 21 174 17 1.50 6.50
Other Special Charges / (Income)		 8.14 20 23 39 12 - 0.00 0.00 0.00 0.00 0.00
Total Other Income / (Expense), net		 -75 -62 -47 -78 -65 -453 -160 -180 -155 -113 -130
Interest Expense		 114 122 106 131 129 376 149 202 196 188 185
Interest & Investment Income		 37 38 42 50 54 -68 13 37 98 94 75
Other Income / (Expense), net		 1.35 21 17 3.73 9.48 -9.60 -23 -16 -58 -19 -20
Income Tax Expense		 129 104 79 95 80 -922 -66 -7.10 88 -176 86
Net Income / (Loss) Attributable to Noncontrolling Interest		 1.86 1.74 1.84 1.48 2.46 -2.20 1.20 6.40 6.60 6.40 6.60
Basic Earnings per Share		 $1.87 $2.19 $2.26 $1.83 $1.63 ($10.50) ($7.10) ($4.52) $3.10 $5.08 $2.36
Weighted Average Basic Shares Outstanding		 115.08M 115.51M 115.77M 116.05M 116.31M 233.40M 234.60M 236.40M 238.20M 239.80M 231.20M
Diluted Earnings per Share		 $1.87 $2.19 $2.26 $1.83 $1.63 ($10.50) ($7.10) ($4.52) $2.68 $4.12 $2.08
Weighted Average Diluted Shares Outstanding		 115.40M 115.78M 116.06M 116.34M 116.61M 233.40M 234.60M 236.40M 304M 309.80M 268.60M
Weighted Average Basic & Diluted Shares Outstanding		 116M 116.50M 116.90M 116.80M 117.40M 118.58M 119.74M 120.59M 184.15K 184.15K 115.71M
Cash Dividends to Common per Share		 $1.00 $1.08 $1.16 $1.28 $1.36 $0.36 - - - - $0.33

Quarterly Income Statements for Cinemark

This table shows Cinemark's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -18 25 46 188 51 -39 94 50 34 -6.40 139
Consolidated Net Income / (Loss)		 156 0.00 98 379 474 -73 195 112 56 -11 283
Net Income / (Loss) Continuing Operations		 22 481 36 243 -328 -117 90 80 -46 -68 144
Total Pre-Tax Income 		190 0.00 95 296 382 -102 281 113 224 -19 407
Total Operating Income		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Gross Profit		 445 579 540 702 425 360 722 645 566 454 853
Total Revenue		 639 579 734 922 814 541 941 858 776 643 1,086
Operating Revenue		 639 579 734 922 814 541 941 858 776 643 1,086
Total Cost of Revenue		 194 0.00 195 220 389 181 219 213 210 189 233
Operating Cost of Revenue		 194 0.00 195 220 389 181 219 213 210 189 233
Total Operating Expenses		 488 49 469 513 914 468 507 531 545 495 553
Selling, General & Admin Expense		 334 0.00 320 366 666 319 357 378 384 341 398
Marketing Expense		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Depreciation Expense		 150 49 149 147 246 149 148 153 156 155 155
Impairment Charge		 4.50 - 0.00 0.00 1.50 - 1.60 0.60 - - 0.00
Other Special Charges / (Income)		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Other Income / (Expense), net		 100 -49 -37 -28 69 -39 -39 -33 -40 -35 -31
Interest Expense		 -52 49 46 48 -0.70 39 39 43 43 35 31
Income Tax Expense		 34 0.00 -2.20 -82 -91 -29 86 0.90 27 -7.60 125
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.80 0.00 1.60 2.20 2.60 0.60 2.40 2.00 1.60 1.20 2.80
Basic Earnings per Share		 ($0.28) $0.40 $0.74 $3.08 $1.06 ($0.64) $1.62 $0.86 $0.52 ($0.12) $2.40
Weighted Average Basic Shares Outstanding		 238.20M 119.50M 239.80M 240M 239.80M 238.80M 227M 227.60M 231.20M 229.40M 230.40M
Diluted Earnings per Share		 ($0.08) $0.38 $0.64 $2.38 $0.91 ($0.64) $1.26 $0.80 $0.66 ($0.12) $2.38
Weighted Average Diluted Shares Outstanding		 304M 152.40M 306.80M 316.40M 309.80M 238.80M 298.20M 247.60M 268.60M 229.40M 232.80M
Weighted Average Basic & Diluted Shares Outstanding		 184.15K 122.53M 184.15K 184.15K 184.15K 115.20M 115.22M 117.66M 115.71M 116.97M 116.10M

Annual Cash Flow Statements for Cinemark

This table details how cash moves in and out of Cinemark's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -50 -27 -39 -96 62 -61 602 36 360 518 -1,256
Net Cash From Operating Activities		 456 463 529 557 562 -665 343 289 899 939 804
Net Cash From Continuing Operating Activities		 456 463 529 557 562 -1,245 696 360 857 1,018 745
Net Income / (Loss) Continuing Operations		 219 257 266 215 194 -1,843 -422 -268 400 637 290
Consolidated Net Income / (Loss)		 219 257 266 215 194 -1,843 -422 -268 400 637 290
Depreciation Expense		 187 207 235 258 256 510 525 471 415 391 403
Amortization Expense		 9.82 -7.43 -5.32 -10 -3.32 -50 -32 -33 -56 -75 -45
Non-Cash Adjustments To Reconcile Net Income		 22 39 38 77 91 177 154 250 44 49 148
Changes in Operating Assets and Liabilities, net		 19 -33 -5.06 17 25 -39 471 -61 55 15 -51
Net Cash From Investing Activities		 -328 -328 -410 -451 -311 -167 -179 -193 -264 -294 -418
Net Cash From Continuing Investing Activities		 -328 -328 -410 -451 -311 -251 -179 -193 -264 -294 -418
Purchase of Property, Plant & Equipment		 -332 -327 -381 -346 -304 -252 -191 -221 -299 -302 -438
Sale of Property, Plant & Equipment		 9.97 3.57 15 3.92 3.16 1.20 12 29 5.80 6.60 19
Divestitures		 - - - - - - 0.00 0.00 30 0.00 0.00
Other Investing Activities, net		 - -1.45 - - - - - 0.00 0.00 1.20 0.00
Net Cash From Financing Activities		 -151 -164 -158 -193 -187 779 80 -104 -251 -206 -1,609
Net Cash From Continuing Financing Activities		 -151 -164 -158 -193 -187 451 95 -90 -236 -191 -1,593
Repayment of Debt		 -32 -254 -8.46 -15 -10 -47 -2,365 -67 -1,497 -1,166 -476
Repurchase of Common Equity		 - - - - - 0.00 -8.20 -8.60 -5.80 -9.80 -409
Payment of Dividends		 -116 -126 -135 -149 -159 0.00 - - 0.00 0.00 -39
Issuance of Debt		 1.38 223 - 0.00 0.00 545 2,367 0.00 1,280 1,000 0.00
Other Financing Activities, net		 -4.77 -6.83 -14 -28 -17 -46 101 -14 -14 -15 -669
Effect of Exchange Rate Changes		 -27 1.27 - -9.22 -2.76 -7.80 -10 -41 - -16 26

Quarterly Cash Flow Statements for Cinemark

This table details how cash moves in and out of Cinemark's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -173 -115 84 91 79 -498 415 -955 -218 -165 437
Net Cash From Operating Activities		 215 -39 366 222 390 -230 551 187 296 -41 720
Net Cash From Continuing Operating Activities		 -62 -47 442 23 210 -232 502 159 312 -50 675
Net Income / (Loss) Continuing Operations		 -244 53 98 379 -217 -73 195 112 56 -11 283
Consolidated Net Income / (Loss)		 -244 53 98 379 -217 -73 195 112 56 -11 283
Depreciation Expense		 99 98 98 97 97 99 99 101 104 103 103
Amortization Expense		 -60 -2.20 -19 -19 -20 5.20 -27 -11 -12 4.40 -28
Non-Cash Adjustments To Reconcile Net Income		 13 -21 14 -69 78 10 1.60 61 71 13 -2.40
Changes in Operating Assets and Liabilities, net		 130 -174 250 -365 271 -273 233 -105 93 -160 320
Net Cash From Investing Activities		 -114 -47 -46 -85 -116 -31 -60 -107 -221 -75 -123
Net Cash From Continuing Investing Activities		 -114 -47 -46 -85 -116 -31 -60 -107 -221 -75 -123
Purchase of Property, Plant & Equipment		 -120 -47 -47 -86 -121 -44 -60 -107 -227 -75 -123
Net Cash From Financing Activities		 -15 -21 -315 147 -17 -251 -23 -1,032 -303 -74 -89
Net Cash From Continuing Financing Activities		 5.10 -25 -304 151 -13 -254 -12 -1,028 -299 -67 -88
Repayment of Debt		 -12 -5.00 -307 -845 -8.00 1.20 -6.00 -466 -5.30 -4.10 -8.00
Repurchase of Common Equity		 -0.80 -8.40 -0.40 - -1.00 -234 -0.60 -40 -135 -41 -26
Payment of Dividends		 - 0.00 - - - -9.90 -9.20 -518 499 -11 -58
Other Financing Activities, net		 18 -11 3.60 -3.90 -3.90 -11 3.80 -3.90 -657 -12 3.90

Annual Balance Sheets for Cinemark

This table presents Cinemark's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 4,126 4,307 4,471 4,482 5,828 5,563 0.00 9,441 9,493 9,963 8,906
Total Current Assets		 715 676 658 559 635 893 0.00 1,533 1,939 2,427 1,284
Cash & Equivalents		 589 561 523 426 488 655 0.00 1,102 1,462 1,885 688
Accounts Receivable		 74 75 89 95 84 25 0.00 243 217 274 313
Inventories, net		 16 17 18 19 22 13 0.00 47 47 62 58
Prepaid Expenses		 13 16 17 15 37 34 0.00 51 101 98 95
Current Deferred & Refundable Income Taxes		 23 7.37 12 3.29 4.08 165 0.00 90 113 109 130
Plant, Property, & Equipment, net		 1,505 1,705 1,828 1,833 1,735 1,615 1,383 1,232 1,162 1,145 2,352
Total Noncurrent Assets		 1,906 1,926 1,985 2,090 3,458 3,055 3,061 2,786 2,690 2,775 4,025
Long-Term Investments		 95 98 120 157 421 176 271 64 83 110 82
Goodwill		 1,248 1,263 1,284 1,276 1,283 1,254 1,249 1,251 1,251 1,240 1,246
Intangible Assets		 340 335 337 331 322 314 311 305 303 301 601
Noncurrent Deferred & Refundable Income Taxes		 2.11 2.05 4.07 9.03 9.37 0.00 0.00 0.00 15 137 143
Other Noncurrent Operating Assets		 222 228 240 317 1,422 1,311 1,231 1,166 1,037 987 1,953
Total Liabilities & Shareholders' Equity		 4,126 4,307 4,471 4,482 5,828 5,563 0.00 9,441 9,493 9,963 8,906
Total Liabilities		 3,016 3,034 3,065 3,073 4,380 4,764 2,330 7,447 7,181 7,069 8,037
Total Current Liabilities		 440 443 469 475 709 606 0.00 1,409 1,453 2,094 1,692
Short-Term Debt		 27 27 33 35 6.60 227 217 241 228 683 443
Accounts Payable		 109 110 110 105 92 71 0.00 144 107 172 1,207
Current Deferred & Payable Income Tax Liabilities		 16 15 17 13 19 5.63 0.00 6.40 8.40 8.00 9.20
Other Current Liabilities		 - - - - 233 16 15 14 14 15 33
Total Noncurrent Liabilities		 2,576 2,590 2,596 2,599 3,671 4,158 1,873 6,472 6,194 5,472 6,345
Long-Term Debt		 1,773 1,782 1,780 1,773 1,771 2,377 0.00 4,497 4,328 3,741 3,738
Capital Lease Obligations		 209 234 251 232 141 1,263 1,181 1,059 927 894 1,769
Noncurrent Deferred Revenue		 385 386 41 39 348 344 - 676 657 637 614
Noncurrent Deferred & Payable Income Tax Liabilities		 148 143 130 154 143 99 0.00 166 199 111 127
Other Noncurrent Operating Liabilities		 61 44 394 401 1,267 75 692 75 82 89 96
Total Equity & Noncontrolling Interests		 1,111 1,273 1,406 1,409 1,448 799 0.00 501 919 1,503 869
Total Preferred & Common Equity		 1,100 1,262 1,394 1,396 1,436 788 0.00 483 901 1,485 852
Total Common Equity		 1,100 1,262 1,394 1,396 1,436 788 -91 507 925 1,509 876
Common Stock		 1,113 1,129 1,141 1,156 1,170 1,246 0.00 2,748 2,797 2,861 3,017
Retained Earnings		 325 454 582 639 687 28 0.00 -1,437 -1,043 -412 -822
Treasury Stock		 -67 -73 -76 -79 -82 -87 -91 -95 -98 -103 -540
Accumulated Other Comprehensive Income / (Loss)		 -272 -247 -253 -319 -340 -399 0.00 -710 -731 -836 -779
Noncontrolling Interest		 11 11 12 12 13 11 12 9.30 9.00 9.00 17

Quarterly Balance Sheets for Cinemark

This table presents Cinemark's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 0.00 9,512 9,446 9,393 9,402 9,704 9,429 9,902 8,908 8,751 9,215
Total Current Assets		 0.00 1,769 1,846 1,801 1,846 2,110 1,855 2,399 1,447 1,081 1,635
Cash & Equivalents		 0.00 1,274 1,377 1,347 1,344 1,630 1,387 1,860 922 523 1,007
Accounts Receivable		 0.00 232 201 212 250 248 229 286 255 275 343
Inventories, net		 0.00 55 54 47 53 59 62 66 60 65 65
Prepaid Expenses		 0.00 117 116 89 103 95 86 98 95 93 104
Current Deferred & Refundable Income Taxes		 0.00 90 98 105 96 79 91 88 114 125 117
Plant, Property, & Equipment, net		 0.00 2,376 2,309 2,319 2,252 2,242 2,245 2,237 2,252 2,347 2,338
Total Noncurrent Assets		 1,569 3,807 3,740 3,721 3,759 3,805 3,785 3,721 3,661 4,075 3,993
Long-Term Investments		 11 78 87 97 92 121 96 88 86 72 79
Goodwill		 1,253 1,256 1,249 1,249 1,244 1,246 1,243 1,245 1,247 1,248 1,248
Intangible Assets		 304 304 303 302 302 301 301 301 300 601 601
Noncurrent Deferred & Refundable Income Taxes		 - - - 60 69 134 203 152 146 179 124
Other Noncurrent Operating Assets		 0.00 2,170 2,101 2,012 2,052 2,003 1,942 1,935 1,882 1,976 1,941
Total Liabilities & Shareholders' Equity		 0.00 9,512 9,446 9,393 9,402 9,704 9,429 9,902 8,908 8,751 9,215
Total Liabilities		 672 8,728 8,494 8,434 8,360 8,275 8,184 8,444 7,950 7,909 8,143
Total Current Liabilities		 0.00 1,481 1,301 1,325 1,553 1,852 1,801 2,082 1,659 1,571 1,802
Short-Term Debt		 0.00 16 16 16 15 470 472 472 476 13 13
Accounts Payable		 0.00 993 823 853 1,080 922 862 1,142 1,041 1,074 1,312
Current Deferred & Payable Income Tax Liabilities		 0.00 5.00 4.20 11 4.60 3.60 12 5.80 9.00 18 13
Other Current Liabilities		 0.00 467 458 446 453 457 456 462 133 467 464
Total Noncurrent Liabilities		 672 7,247 7,193 7,109 6,807 6,423 6,383 6,363 6,292 6,338 6,341
Long-Term Debt		 0.00 4,328 4,328 4,328 4,030 3,741 3,740 3,741 3,739 3,738 3,741
Capital Lease Obligations		 0.00 161 154 191 184 188 212 204 1,712 179 170
Noncurrent Deferred Revenue		 - 667 662 652 648 642 631 626 620 609 602
Noncurrent Deferred & Payable Income Tax Liabilities		 0.00 169 191 174 162 110 117 119 123 133 179
Other Noncurrent Operating Liabilities		 672 1,922 1,859 1,764 1,784 1,741 1,683 1,673 98 1,679 1,649
Total Equity & Noncontrolling Interests		 0.00 784 1,001 1,008 1,092 1,429 1,244 1,458 1,007 842 1,073
Total Preferred & Common Equity		 0.00 764 932 941 1,024 1,410 1,228 1,440 939 825 1,054
Total Common Equity		 -98 788 956 965 1,048 1,434 1,252 1,464 964 849 1,078
Common Stock		 0.00 2,773 2,785 2,810 2,828 2,843 2,878 2,893 2,938 3,035 3,052
Retained Earnings		 0.00 -1,195 -1,007 -991 -895 -518 -496 -313 -721 -856 -624
Treasury Stock		 -98 -98 -98 -103 -103 -103 -322 -322 -464 -560 -586
Accumulated Other Comprehensive Income / (Loss)		 0.00 -693 -725 -751 -782 -788 -809 -794 -789 -770 -765
Noncontrolling Interest		 0.00 20 20 18 18 19 17 18 18 17 19

Annual Metrics And Ratios for Cinemark

This table displays calculated financial ratios and metrics derived from Cinemark's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 8.59% 2.32% 2.49% 7.69% 1.90% -100.00% 0.00% 62.51% 24.93% -0.56% 2.15%
EBITDA Growth		 11.36% 3.62% -0.68% 0.02% -6.07% -285.93% 142.05% -9.88% -28.95% -1.36% 14.13%
EBIT Growth		 13.07% 4.60% -7.76% -4.27% -11.28% -553.36% 98.52% 33.33% -269.23% 66.32% -1.03%
NOPAT Growth		 9.63% 13.13% 0.32% -10.94% -10.95% -557.93% 100.00% 0.00% 0.00% 0.00% 0.00%
Net Income Growth		 12.75% 17.42% 3.58% -19.06% -9.97% -1,050.80% 33.56% 37.55% 177.36% 60.56% -54.47%
EPS Growth		 12.65% 17.11% 3.20% -19.03% -10.93% -744.17% 32.38% 36.34% 159.29% 53.73% -49.51%
Operating Cash Flow Growth		 0.27% 1.54% 14.28% 5.28% 0.91% -218.33% 151.52% -15.53% 210.68% 4.42% -14.34%
Free Cash Flow Firm Growth		 76.95% -67.30% 63.56% 74.90% 180.77% -482.09% 123.96% -14.29% -63.53% -128.44% -77.04%
Invested Capital Growth		 0.82% 9.05% 6.41% 1.36% -14.23% 56.01% -15.46% -15.67% -6.78% 2.07% 3.59%
Revenue Q/Q Growth		 1.69% -0.22% 1.67% 1.53% -0.29% -100.00% 968.76% 12.83% -12.08% 6.10% -1.21%
EBITDA Q/Q Growth		 1.16% -3.93% 1.65% 1.99% -2.95% -627.96% 162.58% -33.27% -20.05% 39.91% 2.11%
EBIT Q/Q Growth		 2.77% -2.88% -0.09% -0.62% -5.06% -298.61% 98.38% -107.04% -18.28% 70.11% -60.66%
NOPAT Q/Q Growth		 1.38% 8.18% 8.03% -23.43% 5.46% -290.37% 100.00% -100.00% -100.00% 0.00% 0.00%
Net Income Q/Q Growth		 5.09% 8.01% 7.34% -25.95% 3.63% -424.45% 35.33% 40.03% 293.61% 50.28% -59.05%
EPS Q/Q Growth		 5.06% 8.96% 6.60% -25.91% 3.16% -251.17% 34.74% 29.04% 143.64% 31.63% -2.80%
Operating Cash Flow Q/Q Growth		 -0.43% -8.84% 6.59% -1.85% -6.97% -23,046.54% 159.97% -41.08% 0.08% 22.80% -10.46%
Free Cash Flow Firm Q/Q Growth		 165.51% -57.78% 89.69% 15.16% 164.71% -254.00% 165.52% 153.38% -81.39% 45.10% 94.82%
Invested Capital Q/Q Growth		 -4.00% 1.21% -0.29% -4.05% -41.68% 64.80% 46.59% -18.84% 4.71% 2.82% -37.77%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 73.18% 72.54% 71.62% 72.43% 70.68% 0.00% 69.16% 69.63% 73.71% 73.65% 73.61%
EBITDA Margin		 21.78% 22.05% 21.37% 19.85% 18.30% 0.00% 31.09% 17.24% 9.81% 9.73% 10.87%
Operating Margin		 14.83% 14.49% 13.11% 12.05% 10.31% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 14.88% 15.21% 13.69% 12.17% 10.60% 0.00% -1.55% -0.64% -1.88% -0.64% -0.63%
Profit (Net Income) Margin		 7.67% 8.80% 8.89% 6.68% 5.90% 0.00% -81.07% -31.15% 19.29% 31.15% 9.31%
Tax Burden Percent		 62.91% 71.21% 77.02% 69.29% 70.81% 66.65% 94.89% 99.08% 87.03% 122.74% 56.09%
Interest Burden Percent		 81.90% 81.22% 84.32% 79.25% 78.70% 175.35% 5,514.53% 4,947.44% -1,180.21% -3,989.18% -2,637.76%
Effective Tax Rate		 37.09% 28.79% 22.98% 30.71% 29.19% 0.00% 0.00% 0.00% 12.97% -22.74% 16.54%
Return on Invested Capital (ROIC)		 10.97% 11.83% 11.02% 9.45% 9.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 7.34% 8.55% 8.44% 5.72% 5.29% 0.00% -39.01% -27.94% 30.64% 69.66% 19.84%
Return on Net Nonoperating Assets (RNNOA)		 8.61% 9.72% 8.84% 5.85% 4.57% 0.00% -306.52% -305.03% 83.29% 78.43% 24.45%
Return on Equity (ROE)		 19.58% 21.55% 19.86% 15.30% 13.57% -164.03% -306.52% -305.03% 83.29% 78.43% 24.45%
Cash Return on Invested Capital (CROIC)		 10.16% 3.17% 4.81% 8.10% 24.32% -78.63% 16.75% 17.01% 7.02% -2.05% -3.52%
Operating Return on Assets (OROA)		 10.29% 10.53% 9.33% 8.76% 6.75% 0.00% -0.84% -0.33% -0.61% -0.20% -0.21%
Return on Assets (ROA)		 5.30% 6.09% 6.06% 4.81% 3.76% 0.00% -44.02% -16.20% 6.25% 9.76% 3.07%
Return on Common Equity (ROCE)		 19.39% 21.35% 19.69% 15.17% 13.45% -162.31% -267.35% -253.01% 83.99% 78.83% 24.58%
Return on Equity Simple (ROE_SIMPLE)		 19.89% 20.35% 19.09% 15.42% 13.50% -233.90% 0.00% -158.39% 65.65% 63.96% 0.00%
Net Operating Profit after Tax (NOPAT)		 266 301 302 269 240 -1,097 0.00 0.00 0.00 0.00 0.00
NOPAT Margin		 9.33% 10.32% 10.10% 8.35% 7.30% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 3.63% 3.27% 2.58% 3.74% 3.71% 36.88% 39.01% 27.94% -30.64% -69.66% -19.84%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 0.00% 0.00% 0.00% 0.00%
Cost of Revenue to Revenue		 26.82% 27.46% 28.38% 27.57% 29.32% 0.00% 30.84% 30.37% 26.29% 26.35% 26.39%
SG&A Expenses to Revenue		 17.97% 17.11% 16.99% 19.03% 19.74% 0.00% 58.62% 47.53% 43.30% 44.31% 46.17%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 58.34% 58.05% 58.51% 60.38% 60.37% 0.00% 112.64% 83.71% 64.34% 63.79% 65.82%
Earnings before Interest and Taxes (EBIT)		 424 444 410 392 348 -1,577 -23 -16 -58 -19 -20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 621 644 639 639 601 -1,117 470 423 301 297 339
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 2.72 2.61 0.00 3,147.46 1.85 0.00 3.12
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 1.19 0.00 1.28 650.09 0.56 0.00 0.88
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 20.41 0.00 0.00 0.00 9.12 0.02 19.79
Dividend Yield		 3.46% 3.16% 3.63% 3.77% 4.08% 7.93% 0.00% 0.00% 0.00% 0.00% 1.42%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 4.90% 0.00% 0.00% 0.00% 10.97% 5,428.66% 5.05%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 2.01 1.33 0.95 585.46 2.22 1.28 2.53
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 1.50 0.00 2.03 651.98 1.85 1.09 2.19
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 8.21 0.00 6.53 3,781.67 18.83 11.25 20.16
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 14.17 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 20.57 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 8.77 0.00 8.95 5,530.08 6.30 3.55 8.49
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 7.61 0.00 5.17 3,149.78 30.56 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.81 1.61 1.47 1.45 1.32 4.84 0.00 11.56 5.97 3.54 5.58
Long-Term Debt to Equity		 1.78 1.58 1.45 1.42 1.32 4.56 0.00 11.08 5.72 3.08 5.32
Financial Leverage		 1.17 1.14 1.05 1.02 0.86 1.80 7.86 10.92 2.72 1.13 1.23
Leverage Ratio		 3.69 3.54 3.28 3.18 3.61 5.07 6.96 18.83 13.33 8.03 7.95
Compound Leverage Factor		 3.02 2.87 2.76 2.52 2.84 8.89 383.96 931.57 -157.31 -320.42 -209.79
Debt to Total Capital		 64.40% 61.62% 59.49% 59.16% 56.99% 82.88% 100.00% 92.04% 85.64% 77.96% 84.80%
Short-Term Debt to Total Capital		 0.87% 0.81% 0.94% 1.02% 0.20% 4.86% 15.53% 3.82% 3.56% 10.01% 3.98%
Long-Term Debt to Total Capital		 63.52% 60.81% 58.55% 58.14% 56.79% 78.02% 84.47% 88.22% 82.08% 67.95% 80.82%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.36% 0.34% 0.34% 0.36% 0.37% 0.24% 0.83% 0.15% 0.14% 0.13% 0.15%
Common Equity to Total Capital		 35.25% 38.05% 40.17% 40.48% 42.64% 16.89% -6.52% 8.05% 14.45% 22.13% 15.32%
Debt to EBITDA		 3.23 3.17 3.23 3.19 3.19 -3.46 2.98 13.70 18.24 17.93 14.33
Net Debt to EBITDA		 2.13 2.15 2.22 2.28 1.68 -2.72 2.40 10.94 13.10 11.20 12.06
Long-Term Debt to EBITDA		 3.19 3.13 3.18 3.14 3.18 -3.26 2.51 13.13 17.48 15.63 13.66
Debt to NOPAT		 7.55 6.79 6.83 7.58 8.01 -3.52 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 4.98 4.60 4.70 5.42 4.21 -2.77 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 7.44 6.70 6.72 7.45 7.98 -3.32 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 0.00 0.00 1.45 -0.61 0.00 128.62 0.35 0.28 0.41
Noncontrolling Interest Sharing Ratio		 0.96% 0.93% 0.86% 0.86% 0.87% 1.05% 12.78% 17.05% -0.83% -0.51% -0.56%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.63 1.53 1.40 1.18 0.90 1.47 0.00 1.09 1.33 1.16 0.76
Quick Ratio		 1.51 1.44 1.30 1.10 0.81 1.12 0.00 0.95 1.16 1.03 0.59
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 247 81 132 231 647 -2,474 593 508 185 -53 -93
Operating Cash Flow to CapEx		 141.68% 143.17% 144.63% 162.77% 187.04% -265.47% 191.83% 150.26% 306.65% 318.24% 192.21%
Free Cash Flow to Firm to Interest Expense		 2.17 0.66 1.24 1.76 5.04 -6.59 3.97 2.52 0.95 -0.28 -0.50
Operating Cash Flow to Interest Expense		 4.01 3.80 4.97 4.24 4.37 -1.77 2.30 1.43 4.60 4.99 4.35
Operating Cash Flow Less CapEx to Interest Expense		 1.18 1.15 1.53 1.64 2.03 -2.44 1.10 0.48 3.10 3.42 2.09
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.69 0.69 0.68 0.72 0.64 0.00 0.54 0.52 0.32 0.31 0.33
Accounts Receivable Turnover		 46.69 39.10 36.43 34.96 36.72 0.00 0.00 0.00 13.34 12.42 10.62
Inventory Turnover		 52.10 48.70 49.26 48.23 46.95 16.92 0.00 0.00 17.15 14.80 13.68
Fixed Asset Turnover		 1.93 1.82 1.69 1.76 1.84 0.00 1.01 1.88 2.56 2.64 2.68
Accounts Payable Turnover		 6.71 7.32 7.71 8.28 9.81 3.57 0.00 0.00 6.42 5.76 4.78
Days Sales Outstanding (DSO)		 7.82 9.33 10.02 10.44 9.94 0.00 0.00 0.00 27.37 29.40 34.38
Days Inventory Outstanding (DIO)		 7.01 7.49 7.41 7.57 7.77 21.57 0.00 0.00 21.28 24.66 26.68
Days Payable Outstanding (DPO)		 54.39 49.87 47.32 44.10 37.21 102.11 0.00 0.00 56.82 63.32 76.40
Cash Conversion Cycle (CCC)		 -39.56 -33.04 -29.89 -26.09 -19.49 0.00 0.00 0.00 -8.17 -9.26 -15.34
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,436 2,657 2,827 2,866 2,458 3,835 3,242 2,734 2,548 2,601 2,694
Invested Capital Turnover		 1.18 1.15 1.09 1.13 1.23 0.00 0.43 0.82 1.16 1.18 1.18
Increase / (Decrease) in Invested Capital		 20 221 170 38 -408 1,377 -593 -508 -185 53 93
Enterprise Value (EV)		 0.00 0.00 0.00 0.00 4,929 5,104 3,067 1,600,404 5,664 3,337 6,824
Market Capitalization		 0.00 0.00 0.00 0.00 3,906 2,057 1,928 1,595,765 1,716 5.70 2,734
Book Value per Share		 $9.49 $10.86 $11.97 $11.95 $12.26 $6.67 ($0.76) $0.00 $7.60 $8,196.12 $7.45
Tangible Book Value per Share		 ($4.21) ($2.89) ($1.95) ($1.81) ($1.45) ($6.60) ($13.80) ($0.01) ($5.16) ($167.26) ($5.69)
Total Capital		 3,120 3,316 3,470 3,449 3,367 4,666 1,398 6,298 6,402 6,821 5,720
Total Debt		 2,009 2,044 2,064 2,040 1,919 3,867 1,398 5,796 5,483 5,318 4,851
Total Long-Term Debt		 1,982 2,017 2,032 2,005 1,912 3,640 1,181 5,556 5,255 4,635 4,623
Net Debt		 1,326 1,384 1,422 1,457 1,010 3,036 1,127 4,630 3,938 3,322 4,081
Capital Expenditures (CapEx)		 322 323 366 342 300 251 179 193 293 295 418
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -286 -301 -301 -307 -556 -142 217 -737 -747 -869 -868
Debt-free Net Working Capital (DFNWC)		 303 260 221 119 -67 513 217 365 715 1,016 -180
Net Working Capital (NWC)		 275 233 189 84 -74 286 0.00 124 486 333 -408
Net Nonoperating Expense (NNE)		 47 44 36 54 46 746 1,225 765 -592 -950 -290
Net Nonoperating Obligations (NNO)		 1,326 1,384 1,422 1,457 1,010 3,036 3,242 2,232 1,629 1,098 1,825
Total Depreciation and Amortization (D&A)		 197 200 230 247 253 460 493 439 358 316 358
Debt-free, Cash-free Net Working Capital to Revenue		 -10.03% -10.32% -10.07% -9.52% -16.92% 0.00% 14.37% -30.03% -24.36% -28.49% -27.87%
Debt-free Net Working Capital to Revenue		 10.61% 8.90% 7.40% 3.71% -2.05% 0.00% 14.37% 14.86% 23.30% 33.32% -5.78%
Net Working Capital to Revenue		 9.65% 7.99% 6.31% 2.62% -2.25% 0.00% 0.00% 5.05% 15.86% 10.93% -13.09%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.87 $2.19 $2.26 $1.83 $1.63 ($5.25) ($3.55) ($4.52) $3.10 $5.08 $2.36
Adjusted Weighted Average Basic Shares Outstanding		 115.08M 115.51M 115.77M 116.05M 116.31M 116.67M 117.25M 236.40M 238.20M 239.80M 231.20M
Adjusted Diluted Earnings per Share		 $1.87 $2.19 $2.26 $1.83 $1.63 ($5.25) ($3.55) ($4.52) $2.68 $4.12 $2.08
Adjusted Weighted Average Diluted Shares Outstanding		 115.40M 115.78M 116.06M 116.34M 116.61M 116.67M 117.25M 236.40M 304M 309.80M 268.60M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $1.63 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 115.92M 120.83M 116.47M 117.05M 117.15M 118.58M 119.74M 120.59M 184.15K 184.15K 115.71M
Normalized Net Operating Profit after Tax (NOPAT)		 277 318 331 318 288 -1,097 14 122 14 1.05 5.43
Normalized NOPAT Margin		 9.71% 10.89% 11.08% 9.88% 8.79% 0.00% 0.92% 4.95% 0.47% 0.03% 0.17%
Pre Tax Income Margin		 12.19% 12.36% 11.55% 9.64% 8.34% 0.00% -85.43% -31.44% 22.17% 25.38% 16.60%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 3.73 3.65 3.85 2.99 2.71 -4.20 -0.16 -0.08 -0.29 -0.10 -0.11
NOPAT to Interest Expense		 2.34 2.47 2.84 2.05 1.86 -2.92 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.90 0.99 0.41 0.38 0.37 -4.87 -1.35 -1.03 -1.79 -1.67 -2.37
NOPAT Less CapEx to Interest Expense		 -0.49 -0.18 -0.60 -0.56 -0.47 -3.59 -1.20 -0.95 -1.50 -1.57 -2.26
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 52.97% 49.04% 50.78% 69.43% 82.17% 0.00% 0.00% 0.00% 0.00% 0.00% 13.41%
Augmented Payout Ratio		 52.97% 49.04% 50.78% 69.43% 82.17% 0.00% -0.67% -1.12% 0.98% 1.03% 154.52%

Quarterly Metrics And Ratios for Cinemark

This table displays calculated financial ratios and metrics derived from Cinemark's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 115,710,385.00 116,971,907.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 115,710,385.00 116,971,907.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - -0.06 1.19
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -39.74% -5.16% -22.08% 5.37% 27.45% -6.65% 28.10% -6.98% -4.67% 18.94% 15.51%
EBITDA Growth		 -67.14% 9.09% -42.25% -13.17% 66.11% 9.83% 34.30% 10.68% 9.09% 3.46% 4.60%
EBIT Growth		 -72.57% 100.00% 0.00% 49.40% 1.44% 0.00% 84.13% -73.33% -925.00% 0.00% 0.00%
NOPAT Growth		 -100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Growth		 154.63% -100.00% -59.69% 99.32% 203.85% 0.00% 100.10% -70.35% -65.49% 85.05% 44.80%
EPS Growth		 95.18% 416.67% -60.00% 95.08% 1,237.50% -268.42% 96.88% -66.39% -8.33% 81.25% 88.89%
Operating Cash Flow Growth		 0.33% -265.68% -24.26% 25.71% 80.92% -488.75% 50.57% -15.68% -24.10% 82.36% 30.63%
Free Cash Flow Firm Growth		 -68.33% -225.03% 127.13% -110.27% -128.44% 91.11% -203.64% -1,774.79% -77.04% -100.28% -208.34%
Invested Capital Growth		 -6.78% 182.03% -3.70% 3.94% 2.07% 5.74% 3.98% 71.15% 3.59% 10.87% 11.80%
Revenue Q/Q Growth		 -26.97% -9.34% 26.76% 25.55% -11.66% -33.60% 73.94% -8.83% -9.47% -17.16% 68.93%
EBITDA Q/Q Growth		 -15.58% 49.44% -30.47% 9.66% 61.50% 6.06% -33.62% 14.49% 5.26% 28.10% -30.30%
EBIT Q/Q Growth		 162.95% 100.00% 0.00% 29.41% 226.19% -95.28% -300.00% -420.00% 21.15% 100.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 -17.95% -100.00% 0.00% 288.41% 25.09% -115.39% 367.63% -42.44% -50.58% -119.64% 2,691.74%
EPS Q/Q Growth		 -106.56% 337.50% 236.84% 271.88% -61.76% -170.33% 296.88% -36.51% -17.50% -118.18% 2,083.33%
Operating Cash Flow Q/Q Growth		 21.97% -118.15% 1,036.57% -39.38% 75.54% -159.07% 339.53% -66.05% 58.01% -113.73% 1,874.14%
Free Cash Flow Firm Q/Q Growth		 -80.17% 5.25% 105.45% -209.22% 45.10% -172.11% 36.47% -1,875.63% 94.82% -207.82% 2.19%
Invested Capital Q/Q Growth		 4.71% -43.67% -8.35% 10.47% 2.82% 1.57% -9.88% 81.84% -37.77% 8.71% -9.13%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 69.67% 100.00% 73.50% 76.16% 52.20% 66.60% 76.74% 75.21% 72.92% 70.64% 78.53%
EBITDA Margin		 9.33% 13.88% 7.61% 6.65% 12.16% 19.42% 7.41% 9.31% 10.82% 16.73% 6.90%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 3.27% 0.00% -3.24% -1.82% 2.60% 0.18% -0.21% -1.21% -1.06% 0.00% 0.00%
Profit (Net Income) Margin		 24.40% 0.00% 13.28% 41.08% 58.17% -13.48% 20.74% 13.10% 7.15% -1.69% 26.00%
Tax Burden Percent		 82.01% 0.00% 102.31% 127.81% 123.91% 71.61% 69.38% 99.20% 24.73% 58.92% 69.34%
Interest Burden Percent		 909.57% 0.00% -400.42% -1,763.69% 1,803.30% -10,180.00% -14,060.00% -1,088.46% -2,736.59% 0.00% 0.00%
Effective Tax Rate		 17.99% 0.00% -2.31% -27.81% -23.91% 0.00% 30.62% 0.80% 12.21% 0.00% 30.66%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 8.07% 0.00% 6.98% 29.90% 34.74% -5.05% 18.40% 5.08% 3.80% -0.63% 22.49%
Return on Net Nonoperating Assets (RNNOA)		 21.95% 0.00% 10.40% 31.17% 39.11% -6.47% 15.30% 9.22% 4.68% -1.04% 22.33%
Return on Equity (ROE)		 21.95% 0.00% 10.40% 31.17% 39.11% -6.47% 15.30% 9.22% 4.68% -1.04% 22.33%
Cash Return on Invested Capital (CROIC)		 7.02% -95.30% 3.77% -3.87% -2.05% -5.58% -3.90% -52.48% -3.52% -10.31% -11.14%
Operating Return on Assets (OROA)		 1.06% 0.00% -0.97% -0.55% 0.82% 0.06% -0.07% -0.41% -0.35% 0.00% 0.00%
Return on Assets (ROA)		 7.90% 0.00% 3.97% 12.33% 18.24% -4.31% 6.91% 4.44% 2.36% -0.60% 9.15%
Return on Common Equity (ROCE)		 22.13% 0.00% 10.18% 30.66% 39.31% -6.37% 15.08% 9.08% 4.70% -1.05% 22.42%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 62.49% 43.31% 44.85% 0.00% 71.45% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -8.07% 0.00% -6.98% -29.90% -34.74% 5.05% -18.40% -5.08% -3.80% 0.63% -22.49%
Return On Investment Capital (ROIC_SIMPLE)		 0.00% - - - 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Cost of Revenue to Revenue		 30.33% 0.00% 26.51% 23.84% 47.80% 33.40% 23.26% 24.79% 27.08% 29.36% 21.47%
SG&A Expenses to Revenue		 52.28% 0.00% 43.56% 39.69% 81.74% 59.07% 37.94% 44.06% 49.49% 52.95% 36.63%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 76.41% 8.53% 63.91% 55.67% 112.18% 86.54% 53.87% 61.94% 70.18% 77.02% 50.88%
Earnings before Interest and Taxes (EBIT)		 21 0.00 -24 -17 21 1.00 -2.00 -10 -8.20 0.00 0.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 60 80 56 61 99 105 70 80 84 108 75
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.85 2.27 2.53 0.00 0.00 2.44 2.37 3.35 3.12 7.77 3.44
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.56 0.72 0.94 0.00 0.00 1.01 1.08 1.02 0.88 2.05 1.10
Price to Earnings (P/E)		 9.12 10.13 18.55 0.02 0.02 12.40 11.84 20.78 19.79 38.64 17.11
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.32% 0.53% 0.86% 1.42% 1.19% 1.10%
Earnings Yield		 10.97% 9.87% 5.39% 4,689.19% 5,428.66% 8.07% 8.45% 4.81% 5.05% 2.59% 5.85%
Enterprise Value to Invested Capital (EV/IC)		 2.22 2.12 2.38 1.06 1.28 2.27 2.50 1.89 2.53 3.40 2.47
Enterprise Value to Revenue (EV/Rev)		 1.85 1.75 1.93 0.93 1.09 2.00 1.85 2.59 2.19 3.09 1.95
Enterprise Value to EBITDA (EV/EBITDA)		 18.83 20.20 24.68 12.60 11.25 19.63 18.42 24.63 20.16 27.50 17.98
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 6.30 6.33 7.59 3.50 3.55 8.03 6.39 9.09 8.49 10.01 5.64
Enterprise Value to Free Cash Flow (EV/FCFF)		 30.56 0.00 62.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 5.97 4.50 3.87 3.08 3.54 3.55 3.03 5.89 5.58 4.67 3.66
Long-Term Debt to Equity		 5.72 4.48 3.86 2.75 3.08 3.18 2.71 5.41 5.32 4.65 3.65
Financial Leverage		 2.72 2.36 1.49 1.04 1.13 1.28 0.83 1.82 1.23 1.67 0.99
Leverage Ratio		 13.33 9.32 10.09 7.88 8.03 8.36 7.57 7.64 7.95 8.71 7.55
Compound Leverage Factor		 121.24 0.00 -40.38 -139.01 144.84 -850.60 -1,064.51 -83.18 -217.65 0.00 0.00
Debt to Total Capital		 85.64% 81.81% 79.48% 75.49% 77.96% 78.05% 75.18% 85.48% 84.80% 82.35% 78.53%
Short-Term Debt to Total Capital		 3.56% 0.28% 0.29% 8.06% 10.01% 8.32% 8.04% 6.87% 3.98% 0.27% 0.25%
Long-Term Debt to Total Capital		 82.08% 81.53% 79.20% 67.42% 67.95% 69.73% 67.14% 78.61% 80.82% 82.08% 78.28%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.14% 0.32% 0.35% 0.33% 0.13% 0.30% 0.31% 0.26% 0.15% 0.36% 0.38%
Common Equity to Total Capital		 14.45% 17.41% 19.69% 24.60% 22.13% 22.09% 24.92% 13.90% 15.32% 17.80% 21.58%
Debt to EBITDA		 18.24 17.30 19.11 20.75 17.93 14.46 13.64 17.88 14.33 10.86 10.75
Net Debt to EBITDA		 13.10 11.79 12.62 12.49 11.20 9.61 7.62 14.84 12.06 9.22 7.77
Long-Term Debt to EBITDA		 17.48 17.24 19.04 18.53 15.63 12.91 12.18 16.44 13.66 10.83 10.71
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.38 0.39 0.39 0.25 0.30 0.48 0.57 0.45 0.41 0.66 0.52
Noncontrolling Interest Sharing Ratio		 -0.83% 13.97% 2.12% 1.63% -0.51% 1.59% 1.49% 1.56% -0.56% -0.69% -0.44%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.33 1.36 1.19 1.14 1.16 1.03 1.15 0.87 0.76 0.69 0.91
Quick Ratio		 1.16 1.18 1.03 1.01 1.03 0.90 1.03 0.71 0.59 0.51 0.75
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 185 -1,613 88 -96 -53 -143 -91 -1,800 -93 -287 -281
Operating Cash Flow to CapEx		 150.21% -83.91% 772.57% 259.95% 337.11% -752.29% 922.07% 175.28% 133.73% -54.13% 584.66%
Free Cash Flow to Firm to Interest Expense		 0.00 -29.75 0.90 -2.62 0.00 -2.91 -1.82 -42.05 -2.18 -8.28 -8.97
Operating Cash Flow to Interest Expense		 0.00 -0.72 3.74 6.05 0.00 -4.67 11.03 4.37 6.91 -1.17 23.01
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -1.58 3.26 3.72 0.00 -5.29 9.83 1.88 1.74 -3.33 19.08
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.32 0.65 0.30 0.30 0.31 0.32 0.33 0.34 0.33 0.35 0.35
Accounts Receivable Turnover		 13.34 0.00 11.72 12.81 12.42 13.64 12.00 12.54 10.62 12.75 10.69
Inventory Turnover		 17.15 0.00 11.19 10.82 14.80 18.03 16.89 16.88 13.68 13.10 12.90
Fixed Asset Turnover		 2.56 0.00 1.22 1.26 2.64 1.32 1.43 1.40 2.68 1.40 1.47
Accounts Payable Turnover		 6.42 0.00 0.58 0.70 5.76 1.15 0.91 1.02 4.78 0.86 0.69
Days Sales Outstanding (DSO)		 27.37 0.00 31.14 28.50 29.40 26.75 30.43 29.11 34.38 28.62 34.13
Days Inventory Outstanding (DIO)		 21.28 0.00 32.62 33.73 24.66 20.25 21.61 21.62 26.68 27.87 28.30
Days Payable Outstanding (DPO)		 56.82 0.00 626.31 523.73 63.32 317.94 402.12 357.85 76.40 425.42 530.05
Cash Conversion Cycle (CCC)		 -8.17 0.00 -562.54 -461.50 -9.26 -270.94 -350.08 -307.12 -15.34 -368.93 -467.61
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,548 2,499 2,290 2,530 2,601 2,642 2,381 4,329 2,694 2,929 2,662
Invested Capital Turnover		 1.16 1.79 1.21 1.16 1.18 1.17 1.38 0.92 1.18 1.16 1.33
Increase / (Decrease) in Invested Capital		 -185 1,613 -88 96 53 143 91 1,800 93 287 281
Enterprise Value (EV)		 5,664 5,298 5,461 2,672 3,337 6,007 5,964 8,165 6,824 9,947 6,562
Market Capitalization		 1,716 2,189 2,649 5.13 5.70 3,049 3,477 3,228 2,734 6,595 3,706
Book Value per Share		 $7.60 $8.07 $8.55 $7,785.59 $8,196.12 $5.11 $12.71 $8.36 $7.45 $2.45 $9.22
Tangible Book Value per Share		 ($5.16) ($4.91) ($4.06) ($613.64) ($167.26) ($1.19) ($0.71) ($5.06) ($5.69) ($2.88) ($6.59)
Total Capital		 6,402 5,543 5,321 5,827 6,821 5,668 5,875 6,934 5,720 4,772 4,996
Total Debt		 5,483 4,535 4,229 4,399 5,318 4,423 4,417 5,927 4,851 3,930 3,923
Total Long-Term Debt		 5,255 4,519 4,214 3,929 4,635 3,952 3,944 5,451 4,623 3,917 3,911
Net Debt		 3,938 3,091 2,793 2,648 3,322 2,941 2,469 4,919 4,081 3,335 2,838
Capital Expenditures (CapEx)		 143 47 47 85 116 31 60 107 221 75 123
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -747 -855 -1,035 -903 -869 -861 -1,070 -658 -868 -1,000 -1,161
Debt-free Net Working Capital (DFNWC)		 715 492 309 727 1,016 526 790 265 -180 -477 -154
Net Working Capital (NWC)		 486 476 294 257 333 54 317 -212 -408 -490 -167
Net Nonoperating Expense (NNE)		 -156 0.00 -98 -379 -474 73 -195 -112 -56 11 -283
Net Nonoperating Obligations (NNO)		 1,629 1,490 1,198 1,101 1,098 1,398 923 3,323 1,825 2,087 1,589
Total Depreciation and Amortization (D&A)		 39 80 80 78 78 104 72 90 92 108 75
Debt-free, Cash-free Net Working Capital to Revenue		 -24.36% -28.17% -36.60% -31.41% -28.49% -28.60% -33.26% -20.86% -27.87% -31.07% -34.52%
Debt-free Net Working Capital to Revenue		 23.30% 16.20% 10.92% 25.30% 33.32% 17.45% 24.54% 8.39% -5.78% -14.82% -4.58%
Net Working Capital to Revenue		 15.86% 15.69% 10.39% 8.95% 10.93% 1.79% 9.86% -6.71% -13.09% -15.21% -4.95%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.28) $0.20 $0.74 $3.08 $1.06 ($0.64) $1.62 $0.86 $0.52 ($0.12) $2.40
Adjusted Weighted Average Basic Shares Outstanding		 238.20M 119.50M 239.80M 240M 239.80M 238.80M 227M 227.60M 231.20M 229.40M 230.40M
Adjusted Diluted Earnings per Share		 ($0.08) $0.19 $0.64 $2.38 $0.91 ($0.64) $1.26 $0.80 $0.66 ($0.12) $2.38
Adjusted Weighted Average Diluted Shares Outstanding		 304M 152.40M 306.80M 316.40M 309.80M 238.80M 298.20M 247.60M 268.60M 229.40M 232.80M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 184.15K 122.53M 184.15K 184.15K 184.15K 115.20M 115.22M 117.66M 115.71M 116.97M 116.10M
Normalized Net Operating Profit after Tax (NOPAT)		 3.69 0.00 0.00 0.00 1.05 0.00 1.11 0.60 0.00 0.00 0.00
Normalized NOPAT Margin		 0.58% 0.00% 0.00% 0.00% 0.13% 0.00% 0.12% 0.07% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 29.75% 0.00% 12.98% 32.14% 46.95% -18.83% 29.90% 13.20% 28.91% -2.88% 37.50%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 -0.24 -0.46 0.00 0.02 -0.04 -0.24 -0.19 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 -0.86 -0.73 -2.78 0.00 -0.60 -1.24 -2.74 -5.36 -2.16 -3.94
NOPAT Less CapEx to Interest Expense		 0.00 -0.86 -0.48 -2.33 0.00 -0.62 -1.20 -2.50 -5.17 -2.16 -3.94
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 13.41% 11.22% 20.10%
Augmented Payout Ratio		 0.98% 1.74% 2.21% 1.52% 1.03% 26.86% 24.19% 38.89% 154.52% 72.53% 74.87%

Financials Breakdown Chart

Key Financial Trends

Cinemark’s Q2 2026 results show a strong seasonal rebound in earnings and cash generation, although the balance sheet remains highly leveraged and liquidity has weakened compared with the prior year. Revenue reached $1.09 billion, up from $940.5 million in Q2 2025 and $874.8 million in Q3 2023. Gross profit increased to $853.2 million, producing an approximately 78.5% gross margin versus 76.7% a year earlier.

Profitability improved sharply from the first quarter. Net income attributable to common shareholders rose to $139.4 million, or $2.40 per diluted share, compared with a $6.4 million loss, or negative $0.12 per share, in Q1 2026. However, Q2 2026 earnings were still below the unusually strong $187.8 million reported in Q3 2024.

Cash flow also strengthened considerably. Operating cash flow was $720.3 million in Q2 2026, compared with $551.4 million in Q2 2025 and negative $40.6 million in Q1 2026. After $123.2 million of capital expenditures and $89.2 million of financing outflows, cash increased by $437.1 million during the quarter.

  • Revenue and gross profit are recovering: Q2 2026 revenue grew approximately 15.7% year over year, while gross profit increased 18.2%. This suggests improved attendance, pricing, concession activity, or a more favorable film slate.
  • Strong quarterly earnings rebound: Common-shareholder earnings improved from a $6.4 million loss in Q1 2026 to $139.4 million in Q2, with diluted EPS rising to $2.38.
  • Operating cash flow reached a multiyear high in the supplied data: Q2 2026 operating cash flow of $720.3 million exceeded the $551.4 million generated in Q2 2025 and the $483.5 million generated in Q2 2023.
  • Cash reserves increased sequentially: Cash and equivalents rose from $523.1 million at the end of Q1 2026 to $1.01 billion at the end of Q2, improving near-term financial flexibility.
  • Interest expense is trending lower: Quarterly interest expense declined to $31.3 million in Q2 2026 from $39.4 million in Q2 2025, $42.8 million in Q3 2024 and more than $100 million in several 2023 quarters.
  • Shareholder returns continued: Cinemark repurchased $25.5 million of common stock and paid $58.0 million in dividends during Q2 2026, signaling continued willingness to return capital while cash generation is strong.
  • Cash flow is helped by working-capital movements: Changes in operating assets and liabilities contributed $319.8 million to Q2 2026 operating cash flow. This is beneficial for liquidity, but investors should determine whether the contribution is recurring or reflects timing-related changes.
  • Capital spending remains meaningful: Property, plant and equipment purchases increased to $123.2 million in Q2 2026 from $60.2 million a year earlier. The spending could support theater improvements and long-term revenue, but it also reduces free cash flow in the near term.
  • Liquidity is thinner than a year ago: Cash declined from $1.86 billion at Q2 2025 to $1.01 billion at Q2 2026. Total current assets of $1.64 billion were below total current liabilities of $1.80 billion, implying a current ratio below 1.0.
  • Leverage remains a major risk: Cinemark had approximately $3.75 billion of long-term debt, $12.6 million of short-term debt and $169.8 million of capital lease obligations at Q2 2026. Total liabilities of $8.14 billion were approximately 7.6 times reported equity of $1.07 billion.

The longer-term pattern is a recovery from the weak and volatile results seen in 2022 and early 2023. Revenue expanded from $650.4 million in Q3 2022 to $1.09 billion in Q2 2026, while interest expense and operating cash flow generally improved from the elevated financing pressure seen in 2023. Still, results remain highly seasonal, and earnings have fluctuated substantially between quarters.

Investors should also note that several historical figures in the supplied data are marked as restated or calculated, and some standardized operating-income fields appear inconsistent with the underlying revenue and expense figures. The reported net income, cash flow and balance-sheet totals provide a more reliable basis for evaluating the current trend. Overall, Q2 2026 was a strong operating quarter, but sustaining cash generation and managing Cinemark’s debt load remain important to the stock’s outlook.

09/04/26 01:50 PM ETAI Generated. May Contain Errors.

Cinemark Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cinemark's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Cinemark's net income appears to be on an upward trend, with a most recent value of $290 million in 2025, rising from $218.73 million in 2015. The previous period was $637 million in 2024. See Cinemark's forecast for analyst expectations on what's next for the company.

Cinemark's total operating income in 2025 was $0.00, based on the following breakdown:
  • Total Gross Profit: $2.29 billion
  • Total Operating Expenses: $2.05 billion

Over the last 10 years, Cinemark's total revenue changed from $2.85 billion in 2015 to $3.12 billion in 2025, a change of 9.2%.

Cinemark's total liabilities were at $8.04 billion at the end of 2025, a 13.7% increase from 2024, and a 166.5% increase since 2015.

In the past 10 years, Cinemark's cash and equivalents has ranged from $0.00 in 2021 to $1.88 billion in 2024, and is currently $688.40 million as of their latest financial filing in 2025.

Over the last 10 years, Cinemark's book value per share changed from 9.49 in 2015 to 7.45 in 2025, a change of -21.5%.


Related Companies

Financial statements for NYSE:CNK last updated on 7/30/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Congress Just Opened the Floodgates
The House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...
Awesomely | Sponsoredtc pixel
FDA Momentum is Building Around NNVC!
NanoViricides (NYSE: NNVC) just received regulatory approval to begin a Phase II trial of NV-387 Oral Gummies ...
Smallcaps Daily | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Near retirement? Buy this stock
On August 9, the Wall Street Journal profiled a unique AI strategy used by three companies. Whitney Tilson of ...
Stansberry Research | Sponsoredtc pixel
Trump’s “new Petrodollar” exposed
Trump has reportedly secured control over 65 billion barrels across 17 Venezuelan oil fields, more than the en...
Porter & Company | Sponsoredtc pixel
Anthropic’s $65 Billion Surge: One backdoor got there first
Anthropic's annualized revenue run rate hit $65 billion, up from $47 billion in May and roughly $9 billion at ...
The Oxford Club | Sponsoredtc pixel